Cargando…

Identification of a Potential PPAR-Related Multigene Signature Predicting Prognosis of Patients with Hepatocellular Carcinoma

Peroxisome proliferator-activated receptors (PPARs) and part of their target genes have been reported to be related to the progression of hepatocellular carcinoma (HCC). The prognosis of HCC is not optimistic, and more accurate prognostic markers are needed. This study focused on discovering potenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Wenfang, Chen, Zhen, Liu, Gang, Dai, Yuping, Xu, Xuanfu, Ma, Duan, Liu, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981186/ https://www.ncbi.nlm.nih.gov/pubmed/33777129 http://dx.doi.org/10.1155/2021/6642939

Ejemplares similares

Identification of an autophagy-related gene signature predicting overall survival for hepatocellular carcinoma
por: Xu, Wenfang, et al.
Publicado: (2021)

Identification of Gene Signatures for Diagnosis and Prognosis of Hepatocellular Carcinomas Patients at Early Stage
por: Gan, Xiaoning, et al.
Publicado: (2020)

A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma
por: Liu, Chang, et al.
Publicado: (2022)

Genomewide identification of a novel six‐LncRNA signature to improve prognosis prediction in resectable hepatocellular carcinoma
por: Wu, Ying, et al.
Publicado: (2018)

An Apoptotic Gene Signature for the Prognosis of Hepatocellular Carcinoma
por: Chen, Kunlun, et al.
Publicado: (2021)

Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis
por: Feng, Jiao, et al.
Publicado: (2020)

Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma
por: Kong, Junjie, et al.
Publicado: (2022)

Identification and validation of novel signature associated with hepatocellular carcinoma prognosis using Single-cell and WGCNA analysis
por: Song, Hang, et al.
Publicado: (2023)

Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma
por: Zhao, Qiu-Jie, et al.
Publicado: (2018)

Predicting Prognosis of Hepatocellular Carcinoma Patients Based on the Expression Signatures of Mitophagy Genes
por: Li, Yan-ke, et al.
Publicado: (2022)

Long Noncoding RNA (lncRNA) MT1JP Suppresses Hepatocellular Carcinoma (HCC) in vitro
por: Mo, Wenhui, et al.
Publicado: (2020)

Prognosis and Personalized Treatment Prediction in Different Mutation-Signature Hepatocellular Carcinoma
por: Zhang, Yuyuan, et al.
Publicado: (2023)

Identification of an Oxidative Stress-Related LncRNA Signature for Predicting Prognosis and Chemotherapy in Patients With Hepatocellular Carcinoma
por: Zhong, Zixuan, et al.
Publicado: (2022)

An Integrating Immune-Related Signature to Improve Prognosis of Hepatocellular Carcinoma
por: Zhu, Rui, et al.
Publicado: (2020)

Identification of Seven-Gene Hypoxia Signature for Predicting Overall Survival of Hepatocellular Carcinoma
por: Bai, Yuping, et al.
Publicado: (2021)

Identification of the Pyroptosis-Related Prognosis Gene Signature and Immune Infiltration in Hepatocellular Carcinoma
por: Yu, Heng, et al.
Publicado: (2022)

Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma
por: Guan, Qiutong, et al.
Publicado: (2022)

Identification of a Novel Metastasis-Related miRNAs-Based Signature for Predicting the Prognosis of Hepatocellular Carcinoma
por: Chen, Yuan, et al.
Publicado: (2021)

Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer
por: Zhu, Ke, et al.
Publicado: (2021)

Angiogenesis-Related Immune Signatures Correlate With Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity in Hepatocellular Carcinoma
por: Yang, Yuan, et al.
Publicado: (2021)

A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma
por: Xu, Kequan, et al.
Publicado: (2022)

Development and validation of an immune‐related prognosis signature associated with hypoxia and ferroptosis in hepatocellular carcinoma
por: Yang, Chun‐Bo, et al.
Publicado: (2022)

Systematic Identification of Novel Ferroptosis-Associated Multigene Models for Predicting Patient Prognosis Based on Endometrial Cancer
por: Liu, Xiqin, et al.
Publicado: (2023)

Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma
por: Hu, Yinan, et al.
Publicado: (2022)

STING pathway contributes to the prognosis of hepatocellular carcinoma and identification of prognostic gene signatures correlated to tumor microenvironment
por: Pu, Zhangya, et al.
Publicado: (2022)

Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels
por: Lin, Xiaozeng, et al.
Publicado: (2022)

Autophagy-Related Gene Pairs Signature for the Prognosis of Hepatocellular Carcinoma
por: Luo, Yiming, et al.
Publicado: (2021)

Identification of an autophagy-related gene signature that can improve prognosis of hepatocellular carcinoma patients
por: Huo, Xingxing, et al.
Publicado: (2020)

Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Huang, Anmin, et al.
Publicado: (2021)

Identification and Validation of a Tumor Microenvironment-Related Gene Signature in Hepatocellular Carcinoma Prognosis
por: Huang, Changjing, et al.
Publicado: (2021)

Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma
por: Ye, Jianzhong, et al.
Publicado: (2023)

A pyroptosis-related gene signature for prognosis prediction in hepatocellular carcinoma
por: Chen, Yongwei, et al.
Publicado: (2023)

Identification of an 11-lncRNA signature with high performance for predicting the prognosis of hepatocellular carcinoma using bioinformatics analysis
por: Wang, Anmei, et al.
Publicado: (2021)

Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma
por: Wang, Qingbin, et al.
Publicado: (2023)

Bioinformatic identification of differentially expressed genes associated with hepatocellular carcinoma prognosis
por: Huang, Xu, et al.
Publicado: (2022)

Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
por: Chen, Cong, et al.
Publicado: (2022)

Identification of an Endoplasmic Reticulum Stress-Related Gene Signature to Evaluate the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma
por: Song, Dingli, et al.
Publicado: (2022)

Single-cell sequencing and bulk RNA sequencing reveal a cell differentiation-related multigene panel to predict the prognosis and immunotherapy response of hepatocellular carcinoma
por: Liu, Jifeng, et al.
Publicado: (2023)

From big data to diagnosis and prognosis: gene expression signatures in liver hepatocellular carcinoma
por: Yang, Hong, et al.
Publicado: (2017)

The Role of PPARγ in Hepatocellular Carcinoma
por: Borbath, Ivan, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_e41e99lfo2o4g791onlhahpc09